Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy

被引:6
作者
Farrar, Michelle A. [1 ,2 ]
Kariyawasam, Didu [1 ,2 ]
Grattan, Sarah [1 ,2 ]
Bayley, Klair [3 ]
Davis, Mark [4 ]
Holland, Sandra [1 ,2 ]
Waddel, Leigh B. [5 ,6 ,7 ]
Jones, Kristi [5 ]
Lorentzos, Michelle [6 ,7 ,8 ]
Ravine, Anja [9 ]
Wotton, Tiffany [9 ]
Wiley, Veronica [9 ]
机构
[1] Sydney Childrens Hosp Network, Dept Paediat Neurol, Sydney, NSW, Australia
[2] UNSW Sydney, UNSW Med & Hlth, Sch Clin Med, Discipline Paediat, Sydney, NSW, Australia
[3] Univ Western Australia, Harry Perkins Inst Med Res, Nedlands, WA, Australia
[4] QEII Med Ctr, Dept Diagnost Genom, PathWest Lab Med, Perth, WA, Australia
[5] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia
[6] Childrens Hosp Westmead, TY Nelson Dept Neurol & Neurosurg, Sydney, NSW, Australia
[7] Childrens Hosp Westmead, Kids Neurosci Ctr, Westmead, NSW, Australia
[8] Univ Sydney, Discipline Paediat, Sydney, NSW, Australia
[9] Childrens Hosp Westmead, NSW Newborn Screening Programme, Westmead, NSW, Australia
基金
英国医学研究理事会;
关键词
Duchenne muscular dystrophy; newborn screening; presymptomatic; implementation; translation; PARENTAL ATTITUDES; EXPERIENCE; MANAGEMENT; EMERGENCY; BENEFIT; CARE;
D O I
10.3233/JND-221535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A pilot newborn screening (NBS) program for Duchenne muscular dystrophy (DMD) study proposes to assess the feasibility of the screening procedure, temporal course of the various steps of screening, and the public acceptability of the program. This is particularly vital to ascertain as DMD is considered a `non-treatable' disease and thus does not fit the traditional criteria for newborn screening. However, modern perspectives of NBS for DMD are changing and point to possible net benefits for children and their families undertaking NBS for DMD. The aim of this workshop was to establish pathways for the successful implementation and evaluation of a pilot NBS for DMD program in Australia. Consensus was reached as to the rationale for, potential benefits, risks, barriers and facilitators of screening, alongside the establishment of screening protocols and clinical referral pathways.
引用
收藏
页码:15 / 28
页数:14
相关论文
共 50 条
  • [41] Treatment of Duchenne muscular dystrophy at the mRNA level
    Matsuo, M
    Takeshima, Y
    FRONTIERS IN HUMAN GENETICS: DISEASES AND TECHNOLOGIES, 2001, : 347 - 356
  • [42] Current treatment of adult Duchenne muscular dystrophy
    Wagner, Kathryn R.
    Lechtzin, Noah
    Judge, Daniel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (02): : 229 - 237
  • [43] Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
    Perry B. Shieh
    Neurotherapeutics, 2018, 15 : 840 - 848
  • [44] Early prednisone treatment in Duchenne muscular dystrophy
    Merlini, L
    Cicognani, A
    Malaspina, E
    Gennari, M
    Gnudi, S
    Talim, B
    Franzoni, E
    MUSCLE & NERVE, 2003, 27 (02) : 222 - 227
  • [45] A novel treatment regimen for Duchenne muscular dystrophy
    Li, Mei
    Cai, Yunting
    Zhong, Min
    Zou, Lin
    Gong, Caihui
    NEUROREPORT, 2013, 24 (16) : 924 - 927
  • [46] Diagnosis and therapy of Duchenne and Becker forms of muscular dystrophy
    Kirschner, J.
    MEDIZINISCHE GENETIK, 2009, 21 (03) : 322 - 326
  • [47] Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy
    Hor, Kan N.
    Mah, May Ling
    Johnston, Pace
    Cripe, Timothy P.
    Cripe, Linda H.
    NEUROMUSCULAR DISORDERS, 2018, 28 (09) : 711 - 716
  • [48] Genotype and age at diagnosis in Thai boys with Duchenne muscular dystrophy (DMD)
    Yamputchong, Pattareeya
    Pho-iam, Theeraphong
    Limwongse, Chanin
    Wattanasirichaigoon, Duangrurdee
    Sanmaneechai, Oranee
    NEUROMUSCULAR DISORDERS, 2020, 30 (10) : 839 - 844
  • [49] Duchenne muscular dystrophy
    Yiu, Eppie M.
    Kornberg, Andrew J.
    NEUROLOGY INDIA, 2008, 56 (03) : 236 - 247
  • [50] Duchenne muscular dystrophy
    Yiu, Eppie M.
    Kornberg, Andrew J.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2015, 51 (08) : 759 - 764